TY - JOUR
T1 - 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary
AU - Soar, Jasmeet
AU - Donnino, Michael W.
AU - Maconochie, Ian
AU - Aickin, Richard
AU - Atkins, Dianne L.
AU - Andersen, Lars W.
AU - Berg, Katherine M.
AU - Bingham, Robert
AU - Böttiger, Bernd W.
AU - Callaway, Clifton W.
AU - Couper, Keith
AU - Couto, Thomaz Bittencourt
AU - De Caen, Allan R.
AU - Deakin, Charles D.
AU - Drennan, Ian R.
AU - Guerguerian, Anne-Marie
AU - Lavonas, Eric J.
AU - Meaney, Peter A.
AU - Nadkarni, Vinay M.
AU - Neumar, Robert W.
AU - Ng, Kee-Chong
AU - Nicholson, Tonia C.
AU - Nuthall, Gabrielle A.
AU - Ohshimo, Shinichiro
AU - O'Neil, Brian J.
AU - Ong, Gene Yong-Kwang
AU - Paiva, Edison F.
AU - Parr, Michael J.
AU - Reis, Amelia G.
AU - Reynolds, Joshua C.
AU - Ristagno, Giuseppe
AU - Sandroni, Claudio
AU - Schexnayder, Stephen M.
AU - Scholefield, Barnaby R.
AU - Shimizu, Naoki
AU - Tijssen, Janice A.
AU - Van De Voorde, Patrick
AU - Wang, Tzong-Luen
AU - Welsford, Michelle
AU - Hazinski, Mary Fran
AU - Nolan, Jerry P.
AU - Morley, Peter T.
PY - 2018
Y1 - 2018
N2 - The International Liaison Committee on Resuscitation has initiated a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation science. This is the second annual summary of International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations that includes the most recent cardiopulmonary resuscitation science reviewed by the International Liaison Committee on Resuscitation. This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria. The statements include consensus treatment recommendations approved by members of the relevant task forces. Insights into the deliberations of each task force are provided in the Values and Preferences and Task Force Insights sections. Finally, the task force members have listed the top knowledge gaps for further research.
AB - The International Liaison Committee on Resuscitation has initiated a continuous review of new, peer-reviewed, published cardiopulmonary resuscitation science. This is the second annual summary of International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations that includes the most recent cardiopulmonary resuscitation science reviewed by the International Liaison Committee on Resuscitation. This summary addresses the role of antiarrhythmic drugs in adults and children and includes the Advanced Life Support Task Force and Pediatric Task Force consensus statements, which summarize the most recent published evidence and an assessment of the quality of the evidence based on Grading of Recommendations, Assessment, Development, and Evaluation criteria. The statements include consensus treatment recommendations approved by members of the relevant task forces. Insights into the deliberations of each task force are provided in the Values and Preferences and Task Force Insights sections. Finally, the task force members have listed the top knowledge gaps for further research.
KW - AHA Scientific Statements
KW - Cardiology and Cardiovascular Medicine
KW - Physiology (medical)
KW - adolescent
KW - anti-arrhythmia agents
KW - cardiac arrest
KW - cardiopulmonary resuscitation
KW - child
KW - infant
KW - ventricular fibrillation
KW - AHA Scientific Statements
KW - Cardiology and Cardiovascular Medicine
KW - Physiology (medical)
KW - adolescent
KW - anti-arrhythmia agents
KW - cardiac arrest
KW - cardiopulmonary resuscitation
KW - child
KW - infant
KW - ventricular fibrillation
UR - http://hdl.handle.net/10807/131647
U2 - 10.1161/CIR.0000000000000611
DO - 10.1161/CIR.0000000000000611
M3 - Article
SN - 1524-4539
VL - 138
SP - e714-e730
JO - Circulation
JF - Circulation
ER -